GGrantIndex
← Leaderboards

Ivana V Yang

National Jewish Health

$13,155,768
Attributed
$32,038,377
Total exposure
15
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.4M · FY200925
$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,038,377 · 15

By mechanism

R01$23,864,360 · 9
U01$4,227,177 · 1
R25$2,140,356 · 1
RC1$916,670 · 1
P01$658,689 · 2
R21$231,125 · 1

Most similar at National Jewish Health

Same institution · by research overlap

Others in their field

Top investigators on “Genes

Research focus

GenesGeneticLungEpigenetic ProcessGene ExpressionExposure ToVariantMethylationComplexRisk FactorsAffectEtiologyPathogenesisGenetic VariantPrevalenceSamplingPhenotypeCohortDna MethylationEnvironmentPathway InteractionsCellsRecruitFuture

Grant awards (53)

Subtyping COre for Research on the Etiology of Type 2 Diabetes (SCORE-T2D)$1,497,803
U01 · FY2025 · DK
Subtyping COre for Research on the Etiology of Type 2 Diabetes (SCORE-T2D)$1,376,896
U01 · FY2025 · DK
Molecular Determinants of Usual Interstitial Pneumonia (UIP)$702,057
R01 · FY2025 · HL
Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease$636,949
R01 · FY2025 · ES
Genetic and epigenomic determinants of hearing loss in Hispanic populations$617,077
R01 · FY2025 · DC
Health AI and Data Science in Cardiovascular and Pulmonary Disease: Application and Bioethics (HARP-BIO)$341,396
R25 · FY2025 · HL
Human Tissue and Cell Core$227,394
P01 · FY2025 · HL · contact PI
Subtyping COre for Research on the Etiology of Type 2 Diabetes (SCORE-T2D)$1,352,478
U01 · FY2024 · DK
Molecular Determinants of Usual Interstitial Pneumonia (UIP)$688,838
R01 · FY2024 · HL
Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease$646,640
R01 · FY2024 · ES
Genetic and epigenomic determinants of hearing loss in Hispanic populations$623,686
R01 · FY2024 · DC
Health AI and Data Science in Cardiovascular and Pulmonary Disease: Application and Bioethics (HARP-BIO)$331,811
R25 · FY2024 · HL
Human Tissue and Cell Core$203,901
P01 · FY2024 · HL · contact PI
Genes and Transcripts that Interact with MUC5B in Pulmonary Fibrosis$737,696
R01 · FY2023 · HL
Molecular Determinants of Usual Interstitial Pneumonia (UIP)$710,155
R01 · FY2023 · HL
Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease$647,711
R01 · FY2023 · ES
Genetic and epigenomic determinants of hearing loss in Hispanic populations$630,284
R01 · FY2023 · DC
PRIDE Academy: Impact of Ancestry and Gender to omics of lung diseases$345,599
R25 · FY2023 · HL
Human Tissue and Cell Core$227,394
P01 · FY2023 · HL · contact PI
Genetic and epigenomic determinants of hearing loss in Hispanic populations$75,618
R01 · FY2023 · DC
Genetic and epigenomic determinants of hearing loss in Hispanic populations$75,618
R01 · FY2023 · DC
New Approaches for Empowering Studies of Asthma in Populations of African Descent$1,919,328
R01 · FY2022 · HL
Molecular Determinants of Usual Interstitial Pneumonia (UIP)$725,907
R01 · FY2022 · HL
Genes and Transcripts that Interact with MUC5B in Pulmonary Fibrosis$677,919
R01 · FY2022 · HL
Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease$659,638
R01 · FY2022 · ES
Genetic and epigenomic determinants of hearing loss in Hispanic populations$643,660
R01 · FY2022 · DC
PRIDE Academy: Impact of Ancestry and Gender to omics of lung diseases$469,799
R25 · FY2022 · HL
Diversity Supplement to PRIDE-AGOLD: Bias in/bias out in data sciences and health artificial intelligence$181,952
R25 · FY2022 · HL
Genes and Transcripts that Interact with MUC5B in Pulmonary Fibrosis$765,374
R01 · FY2021 · HL
Genetic and epigenomic determinants of hearing loss in Hispanic populations$701,948
R01 · FY2021 · DC
Epigenetic Regulation of Immune Pathways in Sarcoidosis$697,552
R01 · FY2021 · HL
PRIDE Academy: Impact of Ancestry and Gender to omics of lung diseases$469,799
R25 · FY2021 · HL
Genes and Transcripts that Interact with MUC5B in Pulmonary Fibrosis$776,881
R01 · FY2020 · HL
Epigenetic Regulation of Immune Pathways in Sarcoidosis$699,263
R01 · FY2020 · HL
Epigenetic Regulation of Immune Pathways in Sarcoidosis$688,427
R01 · FY2019 · HL
Exposure in Epigenetic Regulation of Immune Response in CBD$466,884
R01 · FY2019 · ES
Epigenetic Regulation of Immune Pathways in Sarcoidosis$712,638
R01 · FY2018 · HL
Exposure in Epigenetic Regulation of Immune Response in CBD$482,240
R01 · FY2018 · ES
Exposure in Epigenetic Regulation of Immune Response in CBD$448,525
R01 · FY2017 · ES
Epigenetic marks of in utero exposure to gestational diabetes$678,649
R01 · FY2016 · DK
Exposure in Epigenetic Regulation of Immune Response in CBD$437,315
R01 · FY2016 · ES
Epigenetic marks of in utero exposure to gestational diabetes$660,999
R01 · FY2015 · DK
Exposure in Epigenetic Regulation of Immune Response in CBD$425,671
R01 · FY2015 · ES
Regulation of mRNA and miRNA Expression in Pulmonary Fibrosis by DNA Methylation$114,875
R21 · FY2015 · HL · contact PI
Epigenetic marks of in utero exposure to gestational diabetes$663,321
R01 · FY2014 · DK
Regulation of mRNA and miRNA Expression in Pulmonary Fibrosis by DNA Methylation$116,250
R21 · FY2014 · HL · contact PI
Asthma: An Epidemic Caused by Epigenetics?$575,844
R01 · FY2013 · HL
Asthma: An Epidemic Caused by Epigenetics?$621,661
R01 · FY2012 · HL
Asthma: An Epidemic Caused by Epigenetics?$628,967
R01 · FY2011 · HL
Asthma: An Epidemic Caused by Epigenetics?$641,807
R01 · FY2010 · HL
Peripheral Blood Biomarkers for Idiopathic Interstitial Pneumonia$442,464
RC1 · FY2010 · HL
Asthma: An Epidemic Caused by Epigenetics?$671,613
R01 · FY2009 · HL
Peripheral Blood Biomarkers for Idiopathic Interstitial Pneumonia$474,206
RC1 · FY2009 · HL